News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Approves GE Healthcare’s SenoBright Spectral Mammography Device
October 17, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography unit.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma
November 7, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Wegovy, Casgevy Among Latest FDA Priority Review Voucher Recipients
November 6, 2025
·
3 min read
·
Dan Samorodnitsky
FDA
FDA’s Top Cancer Regulator Declined CDER Directorship
November 6, 2025
·
2 min read
·
Tristan Manalac
Business
Basel Life Sciences Scene Embraces International Companies, Startups
November 6, 2025
·
6 min read
·
Angela Gabriel
